AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 1,666 | -98.4% | 0.00% | – |
| Q1 2022 | $48,000 | -18.6% | 102,766 | 0.0% | 0.00% | – |
| Q4 2021 | $59,000 | -65.5% | 102,766 | -0.4% | 0.00% | – |
| Q3 2021 | $171,000 | -37.1% | 103,138 | -36.7% | 0.00% | – |
| Q2 2021 | $272,000 | +455.1% | 162,900 | +86.2% | 0.00% | – |
| Q1 2019 | $49,000 | +40.0% | 87,500 | 0.0% | 0.00% | – |
| Q4 2018 | $35,000 | -20.5% | 87,500 | 0.0% | 0.00% | – |
| Q3 2018 | $44,000 | -77.2% | 87,500 | 0.0% | 0.00% | – |
| Q2 2018 | $193,000 | +436.1% | 87,500 | +94.9% | 0.00% | – |
| Q1 2017 | $36,000 | -10.0% | 44,901 | +0.0% | 0.00% | – |
| Q4 2016 | $40,000 | +21.2% | 44,900 | 0.0% | 0.00% | – |
| Q3 2016 | $33,000 | -43.1% | 44,900 | 0.0% | 0.00% | – |
| Q2 2016 | $58,000 | -34.8% | 44,900 | +19.7% | 0.00% | – |
| Q2 2015 | $89,000 | – | 37,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |